dronabinol has been researched along with Hyperglycemia, Postprandial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuadros-Tito, P; Elena-González, A; Esteban-Gutiérrez, G | 1 |
| Challapalli, SC; Smith, PJ; Zhang, F | 1 |
2 other study(ies) available for dronabinol and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
[Spice intoxication and hyperglycemia].
Topics: Cannabinoids; Diabetes Mellitus, Type 1; Dronabinol; Hallucinogens; Humans; Hyperglycemia; Hypoglycemic Agents; Illicit Drugs; Insulin Aspart; Insulin Glargine; Male; Synthetic Drugs; Young Adult | 2020 |
Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.
Topics: Animals; Calcium; Capsaicin; Diabetic Neuropathies; Dose-Response Relationship, Drug; Dronabinol; Glucose; Hyperglycemia; Indoles; Nerve Growth Factor; Neurites; Neurogenesis; Neurons; Neuroprotective Agents; PC12 Cells; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Sensory System Agents | 2009 |